Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q38326336)
Watch
English
PARP inhibitors
scientific article
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PMC publication ID
4300021
retrieved
2 September 2017
title
PARP inhibitors
(English)
1 reference
stated in
Europe PubMed Central
PMC publication ID
4300021
retrieved
2 September 2017
author
Hafiz Muhammad Aslam
series ordinal
2
1 reference
stated in
Europe PubMed Central
PMC publication ID
4300021
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25606064%20AND%20SRC:MED&resulttype=core&format=json
retrieved
31 May 2020
author name string
Maheen Anwar
series ordinal
1
1 reference
stated in
Europe PubMed Central
PMC publication ID
4300021
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25606064%20AND%20SRC:MED&resulttype=core&format=json
retrieved
31 May 2020
Shahzad Anwar
series ordinal
3
1 reference
stated in
Europe PubMed Central
PMC publication ID
4300021
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25606064%20AND%20SRC:MED&resulttype=core&format=json
retrieved
31 May 2020
publication date
17 January 2015
1 reference
stated in
Europe PubMed Central
PMC publication ID
4300021
retrieved
2 September 2017
published in
Hereditary Cancer in Clinical Practice
1 reference
stated in
Europe PubMed Central
PMC publication ID
4300021
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25606064%20AND%20SRC:MED&resulttype=core&format=json
retrieved
31 May 2020
volume
13
1 reference
stated in
Europe PubMed Central
PMC publication ID
4300021
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25606064%20AND%20SRC:MED&resulttype=core&format=json
retrieved
31 May 2020
issue
1
1 reference
stated in
Europe PubMed Central
PMC publication ID
4300021
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25606064%20AND%20SRC:MED&resulttype=core&format=json
retrieved
31 May 2020
page(s)
4
1 reference
stated in
Europe PubMed Central
PMC publication ID
4300021
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25606064%20AND%20SRC:MED&resulttype=core&format=json
retrieved
31 May 2020
copyright license
Creative Commons Attribution 4.0 International
start time
17 January 2015
1 reference
stated in
April 2022 Public Data File from Crossref
copyright status
copyrighted
0 references
exact match
https://scigraph.springernature.com/pub.10.1186/s13053-014-0024-8
0 references
cites work
Role of PARP inhibitors in cancer biology and therapy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4300021
retrieved
6 September 2017
Advances in using PARP inhibitors to treat cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4300021
retrieved
6 September 2017
On PAR with PARP: cellular stress signaling through poly(ADP-ribose) and PARP-1.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4300021
retrieved
6 September 2017
Nuclear PARP-1 protein overexpression is associated with poor overall survival in early breast cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4300021
retrieved
6 September 2017
Climbing STAIRs towards clinical trials with a novel PARP-1 inhibitor for the treatment of ischemic stroke.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4300021
retrieved
6 September 2017
Novel targeted therapeutics: inhibitors of MDM2, ALK and PARP.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4300021
retrieved
6 September 2017
A review of PARP inhibitors: from bench to bedside
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4300021
retrieved
6 September 2017
Gene expression profile of BRCAness that correlates with responsiveness to chemotherapy and with outcome in patients with epithelial ovarian cancer.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4300021
retrieved
6 September 2017
Emergence of rationally designed therapeutic strategies for breast cancer targeting DNA repair mechanisms
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4300021
retrieved
6 September 2017
Evolution of poly(ADP-ribose) polymerase-1 (PARP-1) inhibitors. From concept to clinic.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4300021
retrieved
6 September 2017
PARP inhibition: PARP1 and beyond
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4300021
retrieved
6 September 2017
Synthetic lethal targeting of PTEN mutant cells with PARP inhibitors
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4300021
retrieved
6 September 2017
Recent advances in cancer therapy targeting proteins involved in DNA double-strand break repair.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4300021
retrieved
6 September 2017
Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4300021
retrieved
6 September 2017
Phase I study of the poly(ADP-ribose) polymerase inhibitor, AG014699, in combination with temozolomide in patients with advanced solid tumors.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4300021
retrieved
6 September 2017
The expanding field of poly(ADP-ribosyl)ation reactions. 'Protein Modifications: Beyond the Usual Suspects' Review Series.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4300021
retrieved
6 September 2017
The diverse biological roles of mammalian PARPS, a small but powerful family of poly-ADP-ribose polymerases.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4300021
retrieved
6 September 2017
Role of poly(ADP-ribose) polymerase 1 (PARP-1) in cardiovascular diseases: the therapeutic potential of PARP inhibitors
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4300021
retrieved
6 September 2017
Poly(ADP-ribose): novel functions for an old molecule
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4300021
retrieved
6 September 2017
Poly(ADP-ribosyl)ation in relation to cancer and autoimmune disease
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4300021
retrieved
6 September 2017
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4300021
retrieved
6 September 2017
PARP-1, PARP-2 and ATM in the DNA damage response: functional synergy in mouse development
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4300021
retrieved
6 September 2017
The PARP superfamily
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4300021
retrieved
6 September 2017
Nicotinamide mononucleotide activation of a new DNA-dependent polyadenylic acid synthesizing nuclear enzyme
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4300021
retrieved
6 September 2017
In vitro and in vivo radiosensitization of glioblastoma cells by the poly (ADP-ribose) polymerase inhibitor E7016.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4300021
retrieved
14 September 2017
The selective poly(ADP-ribose) polymerase-1(2) inhibitor, CEP-8983, increases the sensitivity of chemoresistant tumor cells to temozolomide and irinotecan but does not potentiate myelotoxicity
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4300021
retrieved
14 September 2017
PARP inhibition sensitizes p53-deficient breast cancer cells to doxorubicin-induced apoptosis.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4300021
retrieved
23 June 2018
Inhibition of poly(ADP-ribose) polymerase attenuates the severity of acute pancreatitis and associated lung injury.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4300021
retrieved
31 August 2018
Poly(ADP-ribose) is required for spindle assembly and structure.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4300021
retrieved
31 August 2018
Deficiency in the repair of DNA damage by homologous recombination and sensitivity to poly(ADP-ribose) polymerase inhibition
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/25606064
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Identifiers
DOI
10.1186/S13053-014-0024-8
1 reference
stated in
Europe PubMed Central
PMC publication ID
4300021
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25606064%20AND%20SRC:MED&resulttype=core&format=json
retrieved
31 May 2020
Dimensions Publication ID
1009620127
0 references
PMC publication ID
4300021
1 reference
stated in
Europe PubMed Central
PMC publication ID
4300021
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25606064%20AND%20SRC:MED&resulttype=core&format=json
retrieved
31 May 2020
PubMed publication ID
25606064
1 reference
stated in
Europe PubMed Central
PMC publication ID
4300021
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25606064%20AND%20SRC:MED&resulttype=core&format=json
retrieved
31 May 2020
ResearchGate publication ID
271223786
0 references
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit